Status:
UNKNOWN
Acute Phase Proteins as Early Markers in Sepsis
Lead Sponsor:
University of Zurich
Conditions:
Sepsis
Eligibility:
All Genders
18-65 years
Brief Summary
Monitoring of different serumproteins after severe trauma and during trauma-induced sepsis. * Trial with surgical intervention
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients with severe trauma (ISS score \> 16), both genders, patients on ICU
- Exclusion criteria:
- Moribund patients (pH \<7,1, lactate \>15mmol, Basedeficit \> 15mEq/L, severe heart or liver injuries, GCS never over 5 after trauma)
- Severe head injuries (AIS head \>4)
- Patient with severe infectious diseases, or diseases which severely affect the immune system (diabetes, Alkohol or nicotine abuse)
- Non-german speaking patients
Exclusion
Key Trial Info
Start Date :
April 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2012
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00641355
Start Date
April 1 2008
End Date
September 1 2012
Last Update
March 24 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zurich, Switzerland